Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Steuber

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cancer|September 1, 1987
Malignant rhabdoid tumor of the extremityA L Kent, D H Mahoney, M V Gresik, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Essential thrombocythemia in a child: management with anagrelideM M Chintagumpala, C P Steuber, D H Mahoney, et al.
Medical and Pediatric Oncology|January 11, 1992
Soft-tissue sarcomas other than rhabdomyosarcoma in childrenA Hayani, D H Mahoney, H K Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trialD H Mahoney, J Shuster, R Nitschke, et al.
The Journal of Pediatrics|July 1, 1979
An outbreak of aspergillosis in children with acute leukemiaD H Mahoney, C P Steuber, K A Starling, et al.
Investigational New Drugs|December 1, 1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C)C P Steuber, V J Land, C I Civin, et al.
Medical and Pediatric Oncology|January 1, 1978
Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemiaC P Steuber, G J Levy, W L Nix, et al.
Cancer Treatment Reports|May 1, 1976
Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in childrenW W Sutow, D Thomas, C P Steuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer|September 1, 1987
Malignant rhabdoid tumor of the extremityA L Kent, D H Mahoney, M V Gresik, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Essential thrombocythemia in a child: management with anagrelideM M Chintagumpala, C P Steuber, D H Mahoney, et al.
Medical and Pediatric Oncology|January 11, 1992
Soft-tissue sarcomas other than rhabdomyosarcoma in childrenA Hayani, D H Mahoney, H K Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trialD H Mahoney, J Shuster, R Nitschke, et al.
The Journal of Pediatrics|July 1, 1979
An outbreak of aspergillosis in children with acute leukemiaD H Mahoney, C P Steuber, K A Starling, et al.
Investigational New Drugs|December 1, 1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C)C P Steuber, V J Land, C I Civin, et al.
Medical and Pediatric Oncology|January 1, 1978
Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemiaC P Steuber, G J Levy, W L Nix, et al.
Cancer Treatment Reports|May 1, 1976
Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in childrenW W Sutow, D Thomas, C P Steuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Pageof 7